<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "interferon alfa-2b inj PEN">
<dose><value>3</value>
<value>9</value>
<value>36</value>
</dose><route><value>SC</value>
</route><form><value>inj PEN</value>
</form><drugname><value>interferon alfa-2b inj PEN</value>
</drugname><strength><value>15 million unit/mL</value>
<value>25 million unit/mL</value>
<value>50 million unit/mL</value>
</strength><frequency><value>THREE TIMES WEEKLY</value>
<value>DAILY</value>
</frequency><instruction></instruction><volume><value>1.2 mL</value>
</volume><units><value>million unit</value>
</units><additionalnotes><value>Chronic Hepatitis C</value>
<value>Hairy Cell Leukemia treatment for 16 to 24 weeks</value>
<value>Chronic myelogenous leukemia (chronic phase)</value>
<value>Aids-related Kaposi's sarcoma: treatment for 10 to 12 weeks, followed by dose administered 3 times weekly.</value>
<value>Aids-related Kaposi's sarcoma</value>
</additionalnotes><population></population><indicationprn></indicationprn><backgroundinformation><value>Monitor blood pressure, heart rate and rhythm, temperature and hematologic indices.</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antivirals, Interferons</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>02240693</value>
<value>02240694</value>
<value>02240695</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>